AccessClosure is pioneering innovative access site management products designed to address complex challenges in the cardiovascular and peripheral vascular markets. Our products offer easy, effective solutions to vascular closure while maintaining patient comfort. Because vascular disease affects millions of people, our products have the potential to touch the lives of physicians, patients, and their families around the world.

As a company, AccessClosure is a well-funded, high-growth company with a strong venture capital backing. The Mynx Vascular Closure Device, which has been on the market since 2007, has become the leading extravascular solution within three years of launch.

We are always looking for talented people with the skills, vision, and commitment to help us continue to make a difference in the lives of the millions of people that undergo cardiac catheterization procedures each year.

AccessClosure is proud to offer a competitive, comprehensive benefits package that includes:

• Medical
• Dental
• Vision
• Life, AD&D, STD and LTD Insurance
• 401(k) Plan
• Flex Spending Accounts
• Paid Time Off (PTO) Program

We are currently recruiting for the following positions:

Mynx Procedure

The Mynx Product Family of Vascular Closure Devices deliver an extravascular sealant that provides hemostasis without sutures or metal implants. Available in 5F and 6F/7F sizes, the Mynx devices seal the arteriotomy using a unique bio-inert sealant that is absorbed by the body within 30 days, leaving nothing behind but a healed artery.

 

---

STEP 1 - DEPLOY THE BALLOON

Achieve temporary hemostasis at the arteriotomy

 

---

 

 

STEP 2 - PLACE THE SEALANT

Deliver and un-sleeve the sealant, exposing it to blood and subcutaneous fluids:

• The Mynx Cadence device provides extravascular closure through targeted placement of the original Mynx Sealant over the arteriotomy, producing a durable hemostasis.
• The MynxGrip device utilizes the MynxGrip Sealant, which effectively grips the artery and provides secure, extravascular closure.

 

---

 

 

STEP 3 - REMOVE THE DEVICE

Deflate the balloon and remove device. The sealant is now on the surface of the arteriotomy, providing a platform for natural vessel healing.

 

---

 

 

FINAL RESULT

Within 30 days, the sealant dissolves, leaving nothing behind but a healed artery.

 

---

 

 

MynxGrip Procedure Animation

 

Mynx Cadence Procedure Animation

 

Place an Order
• Ordering Information
• Indications and Important Safety Information

Instructions for Use
• Indications and Important Safety Information

 

Quality

R&D

Regulatory

Sales/Marketing

Recruiters and Placement Agencies more >

AccessClosure is an equal opportunity employer. more >